Ashland Analysis (March) 2026 | Price, Valuation & Outlook

Ashland

NYSE:ASH

$ 54,20

+ $0,59 (1,10%)

54,20 $

+$0,59 (1,10%)

End-of-day quote: 03/26/2026

Ashland Stock Value

According to analysts, the current valuation of Ashland is Outperform.

Outperform

Ashland Company Info

EPS Growth 5Y

3,84%

Market Cap

$2,48 B

Long-Term Debt

$1,38 B

Short Interest

6,79%

Quarterly earnings

04/29/2026 (E)

Dividend

$1,68

Dividend Yield

3,10%

Founded

1924

Industry

Materials

Country

United States

ISIN Number

US0441861046

Website

http://www.ashland.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

$70,00

29.15%

Last Update: 03/26/2026

Analysts: 10

Highest Price Target $73,00

Average Price Target $70,00

Lowest Price Target $60,00

In the last five quarters, Ashland’s Price Target has fallen from $132,37 to $89,30 - a -32,54% decrease. Twelve analysts predict that Ashland’s share price will increase in the coming year, reaching $70,00. This would represent an increase of 29,15%.

Top growth stocks in the materials sector (5Y.)

What does Ashland do?

Ashland Inc. (Ashland) is a global specialty additives and materials company. The company serves customers in a wide range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, personal care and pharmaceutical. Ashland serves customers in more than 100 countries. Ashland’s reportable segments include Life Sciences; Personal Care; Specialty Additives; and Intermediates. Life Sciences is consisted of pharmaceuticals, nutrition, agricultur...

Ashland Inc. (Ashland) is a global specialty additives and materials company.

The company serves customers in a wide range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, personal care and pharmaceutical. Ashland serves customers in more than 100 countries.

Ashland’s reportable segments include Life Sciences; Personal Care; Specialty Additives; and Intermediates.

Life Sciences is consisted of pharmaceuticals, nutrition, agricultural chemicals, diagnostic films (formerly known as advanced materials) and fine chemicals. Pharmaceutical solutions include controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers and tablet binders. Nutrition solutions include thickeners, stabilizers, emulsifiers and additives for enhancing mouthfeel, controlling moisture migration, reducing oil uptake and binding structured foods. Customers include pharmaceutical, food, beverage, hospitals and radiologists and industrial manufacturers. The nutraceuticals business was sold in August 2024.

Personal Care is consisted of biofunctionals, microbial protectants (preservatives), skin care, sun care, oral care, hair care and household solutions. These businesses have a broad range of natural, nature-derived, biodegradable, and high-performance ingredients for customer-driven solutions to help protect, renew, moisturize and revitalize skin and hair, and provide solutions for toothpastes, mouth washes and rinses, denture cleaning and care for teeth. Personal Care supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers for household, industrial and institutional cleaning products. Customers include formulators at large multinational branded consumer products companies and smaller, independent boutique companies.

Specialty Additives is consisted of rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive and various industrial markets. Solutions include coatings additives for architectural paints, finishes and lacquers, cement- and gypsum-based dry mortars, ready-mixed joint compounds, synthetic plasters for commercial and residential construction, and specialty materials for industrial applications. Products include rheology modifiers (cellulosic and associative thickeners), foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, and environmental filters, ingredients that aid the manufacturing process of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals and alloys for welding. Products help improve desired functional outcomes through rheology modification and control, water retention, workability, adhesive strength, binding power, film formation, deposition and suspension and emulsification. Customers include global paint manufacturers, electronics and automotive manufacturers, textile mills, the construction industry and welders.

Intermediates is consisted of the production of 1,4 butanediol (‘BDO’) and related derivatives, including n-methylpyrrolidone. These products are used as chemical intermediates in the production of engineering polymers and polyurethanes, and as specialty process solvents in a wide array of applications including electronics, pharmaceuticals, water filtration membranes and more. BDO is also supplied to Life Sciences, Personal Care, and Specialty Additives for use as a raw material.

Life Sciences segment

Life Sciences segment is a supplier of excipients and tablet coating systems to the pharmaceutical and nutrition industries. Excipients include a comprehensive range of polymers for use as tablet binders, super disintegrants, sustained-release agents and drug solubilizers, as well as a variety of coating formulations for immediate, delayed, and sustained release applications. Core products include cellulosics and vinyl pyrrolidone polymers which are used primarily in oral solid dosage drug formulations. Its nutrition portfolio provides functional benefits in areas such as thickening, texture control, thermal gelation, structure enhancement, water binding, clarification and stabilization. Its core products include cellulose gums and vinyl pyrrolidone polymers which are used in a wide range of offerings for bakery, beverage, dairy, desserts, meat products, pet food, prepared foods, sauces and savory products.

Life Sciences segment operates throughout the Americas, Europe and the Asia Pacific. It has 14 manufacturing and lab facilities in nine countries which serve its various end markets. It has manufacturing facilities and labs in Wilmington, Delaware; Calvert City, Kentucky; Columbus, Ohio; Fiskeville, Rhode Island; and Texas City, Texas within the United States; Cabreuva and Sao Paolo, Brazil; Shanghai, China; Dusseldorf, Germany; Hyderabad, India; Mullingar, Ireland; Mexico City, Mexico; Bangkok, Thailand; and Istanbul, Turkey.

Life Science segment markets and distributes its products in the Americas, Europe, the Middle East, Africa and Asia Pacific.

Personal Care segment

The Personal Care segment portfolio of oral care products delivers active ingredients in toothpaste and mouthwashes; provides bioadhesive functionality for dentures; delivers flavor, texture and other functional properties; and provides product binding to ensure form and function throughout product lifecycle.

The Personal Care segment portfolio of hair care products includes advanced styling polymers, fixatives, conditioning polymers, emulsifiers, preservatives, rheology modifiers and biofunctional actives.

The Personal Care segment portfolio of ingredients and solutions for skin care, sun care, and cosmetics focuses on natural and sustainable solutions. Ashland’s Personal Care business includes biofunctional actives, preservatives, and specialty polymers to provide functionality such as water resistance and rheology. Ashland’s natural ingredients include a wide range of cellulose, guar, and cassia derivatives; unique active ingredients derived from botanical sources using exclusive Ashland technologies such as Zeta Fraction and PSR technology; emollients based on natural chemistries; encapsulation technology derived from alginates; and efficacious preservative blends inspired by nature.

The Personal Care segment portfolio of products and technologies is used in many types of cleaning and fragrance applications, including fabric care, home care and dishwashing. Personal Care products are used in a variety of applications for viscosity enhancement, particle suspension, rheology modification, stabilization and fragrance enhancement.

Personal Care segment operates throughout the Americas, Europe and the Asia Pacific. It has 14 manufacturing and lab facilities in nine countries which serve its various end markets and participates in one joint venture. It has manufacturing facilities and labs in Freetown, Massachusetts; Chatham, New Jersey; Ossining, New York; Merry Hill, North Carolina; Kenedy, Texas; and Menomonee Falls, Wisconsin within the United States; Sao Paulo, Brazil; Shanghai, China; Sophia Antipolis, France; Hamburg, Germany; Mumbai, India; Mexico City, Mexico; Zwijndrecht, Netherlands and Poole, United Kingdom.

Personal Care segment markets and distributes its products in the Americas, Europe, the Middle East, Africa and Asia Pacific.

Specialty Additives segment

Specialty Additives segment offers industry-leading products, technologies and resources for solving formulation and product-performance challenges. Using synthetic and semisynthetic polymers derived from polyester and polyurethane-based adhesives, and plant and seed extract, Specialty Additives segment offers comprehensive and innovative solutions for industrial applications.

Key customers include manufacturers of paint, coatings and construction materials; packaging and converting companies; and oilfield service companies.

The areas of expertise include organic and synthetic chemistry, colloid science, rheology, structural analysis and microbiology.

The solutions provide an array of properties, including thickening and rheology control, binding power, film formation, conditioning and deposition, colloid stabilization and suspension.

Specialty Additives segment is composed of various end use markets. Many of the products of the end markets are produced in shared manufacturing facilities, to better manage capacity and achieve desired returns.

Specialty Additives segment provides products and services to over 30 industries. Ashland offers a broad spectrum of organo- and water-soluble polymers that are derived from both natural and synthetic resources. Product lines include derivatized cellulose polymers, synthetics, and vinyl pyrrolidone polymers that impart effective functionalities to serve a variety of industrial markets and specialized applications. Many of the products within Specialty Additives function as performance additives that deliver high levels of end-user value in formulated products. In other areas, such as plastics and textiles, Specialty Additives’ products function as a processing aid, improving the quality of end products and reducing manufacturing costs.

Specialty Additives segment is a recognized leader in rheology solutions for waterborne architectural paint and coatings. Products include hydroxyethylcellulose (‘HEC’), which provides thickening and application properties for interior and exterior paints, and nonionic synthetic associative thickeners (‘NSATs’), which are APEO-free liquid synthetics for high-performance paint and industrial coatings. The Specialty Additives market complements its rheology offering with a broad portfolio of performance foam-control agents, surfactants and wetting agents, dispersants and pH neutralizers.

Specialty Additives segment is a major producer and supplier of cellulose ethers and companion products for the construction industry. These products control properties such as water retention, open time, workability, adhesion, stabilization, pumping, sag resistance, rheology, strength, appearance and performance in dry-mortar formulations.

Specialty Additives segment is a leading global manufacturer of synthetic- and cellulosic-based products for drilling fluids, oil-well cement slurries, completion and workover fluids, fracturing fluids and production chemicals. Specialty Additives offers the oil and gas industry solutions for drilling, stimulation, completion, cementing and production applications.

Specialty Additives segment operates throughout the Americas, Europe and the Asia Pacific. It has 11 manufacturing and lab facilities in nine countries which serve its various end markets. Specialty Additives has manufacturing facilities and labs in Parlin, New Jersey; and Hopewell, Virginia within the United States and Doel-Beveren, Belgium; Nanjing and Shanghai, China; Alizay, France; Dusseldorf, Germany; Mumbai, India; Zwijndrecht, the Netherlands; Singapore, Singapore; and Newton Aycliffe, United Kingdom.

Specialty Additives segment markets and distributes its products in the Americas, Europe, the Middle East, Africa and Asia Pacific.

Intermediates segment

Intermediates segment is a producer of BDO and related derivatives, including n-methylpyrrolidone. These products are used as chemical intermediates in the production of engineering polymers and polyurethanes, and as specialty process solvents in a wide array of applications including electronics, pharmaceuticals, water filtration membranes and more. BDO is also supplied to Life Sciences, Personal Care and Specialty Additives for use as a raw material.

Key customers include Ashland’s Life Sciences, Personal Care and Specialty Additives segments, general industrial manufacturers, plastics and polymers producers, pharmaceutical companies, agricultural firms and producers of electronic components and systems.

Intermediates segment has a manufacturing facility in Lima, Ohio, while some derivatives are produced at Life Sciences facilities in Texas City, Texas and Calvert City, Kentucky. Intermediates segment markets and distributes its products in the Americas, Europe, and Asia Pacific.

Environmental Matters

Ashland maintains a company-wide environmental policy overseen by the Environmental, Health, Safety and Quality Committee of Ashland’s Board of Directors (the ‘Board’).

Many of Ashland’s products and operations are subject to chemical control laws of the countries in which they are located. These laws include regulation of chemical substances and inventories under the Toxic Substances Control Act (‘TSCA’) in the United States and the Registration, Evaluation and Authorization of Chemicals (‘REACH’) regulation in Europe as well as new cosmetic ingredients filings in China under the Cosmetics Supervision and Administration Regulation (‘CSAR’).

In the United States, the Clean Air Act (‘CAA’) imposes stringent limits on facility air emissions, establishes a federally mandated operating permit program, allows for civil and criminal enforcement actions and sets limits on the volatile or toxic content of many types of industrial materials and consumer products. The CAA establishes national ambient air quality standards (‘NAAQS’) with attainment deadlines and control requirements based on the severity of air pollution in a given geographical area. Various state clean air acts implement, complement and, in many instances, add to the requirements of the federal CAA. The requirements of the CAA and its state counterparts have a significant impact on the daily operation of Ashland’s businesses and, in many cases, on product formulation and other long-term business decisions. Other countries where Ashland operates also have laws and regulations relating to air quality. Ashland’s businesses maintain numerous permits and emission control devices pursuant to these clean air laws.

In the United States, Ashland’s facilities are subject to RCRA and its regulations governing generators of hazardous waste. Ashland has implemented systems to oversee compliance with the RCRA regulations.

Seasonality

Ashland’s business units typically experience stronger demand during warmer weather months.

Research and Development

The company's research and development costs were $51 million in 2023.

History

The company was founded in 1924. It was incorporated in 2016. The company was formerly known as Ashland Inc. and changed its name to Ashland Global Holdings Inc. in September 2016 and then to Ashland Inc. in 2022.

Ashland Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Revenue distribution by industry:** - Specialty chemicals: 60% - Pharmaceutical products: 25% - Personal care and household: 15% **TOP 3 markets:** - USA: 40% - Europe: 30% - Asia-Pacific: 20% Ashland Inc. generates the majority of its revenue from the specialty chemicals industry, which account...

At which locations are the company’s products manufactured?

**Production sites of Ashland Inc.:** Ashland Inc. operates several production facilities worldwide to manufacture its chemical products. The key locations include: 1. **USA:** Ashland has multiple production plants in the United States, including in Kentucky, Ohio, and Texas. These sites are cent...

What strategy does Ashland pursue for future growth?

**Revenue Growth:** Estimated 4-6% annually (2026) **Strategy:** Focus on specialty chemicals and sustainable solutions Ashland Inc. is pursuing a growth strategy aimed at strengthening its portfolio in the specialty chemicals sector. The company plans to develop innovative and sustainable product...

Which raw materials are imported and from which countries?

**Main raw materials:** Cellulose, solvents, resins, polymers **Main importing countries:** USA, Germany, China, India Ashland Inc. is a globally active company operating in the specialty chemicals industry. The company imports a variety of raw materials necessary for the production of its produc...

How strong is the company’s competitive advantage?

**Competitive Advantage:** Moderate to strong (estimated 2026) Ashland Inc. has achieved a moderate to strong competitive advantage in the specialty chemicals industry through its focus on high-quality and innovative products. The company benefits from a diversified product portfolio that is used i...

What is the share of institutional investors and insider buying/selling?

**Institutional Investor Share:** 91% (estimated, 2026) **Insider Trades:** No significant transactions (estimated, 2026) The institutional investor share at Ashland Inc. is traditionally high and is estimated to be around 91% for 2026. This demonstrates a strong confidence from institutional inv...

What percentage market share does Ashland have?

**Market share of Ashland Inc.:** Estimated 5% (2026) **Main competitors and their market shares:** 1. **BASF SE:** 15% 2. **Dow Inc.:** 12% 3. **Eastman Chemical Company:** 10% 4. **Huntsman Corporation:** 8% 5. **Celanese Corporation:** 6% 6. **Ashland Inc.:** 5% 7. **Clariant AG:** 4% 8. **Evoni...

Is Ashland stock currently a good investment?

**Revenue Growth:** 3.5% (2025) **EBITDA Margin:** 22% (2025) **Free Cash Flow:** $450 million (2025) Ashland Inc. recorded a moderate revenue growth of 3.5% in 2025. This indicates stable demand for their products, especially in the specialty chemicals and additives sectors. The EBITDA margi...

Does Ashland pay a dividend – and how reliable is the payout?

**Dividend Yield:** 1.6% (2026, estimated) **Dividend History:** Continuous payouts over the last 5 years Ashland Inc. pays a dividend currently estimated at around 1.6%. The company has been consistently distributing dividends over the past five years, indicating a certain level of reliability....

New support ticket

Explore

Ashland Stock Value

Ashland Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the materials sector (5Y.)

What does Ashland do?

Ashland Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Ashland Stock Value

Ashland Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the materials sector (5Y.)

What does Ashland do?

Ashland Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.